Notice: Prescription Drug List (PDL): Naloxone
The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL).
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): NaloxoneHTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): NaloxoneHTMLFrench publication HTML
Similar records